Literature DB >> 29365319

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

E Dianne Pulte1, Lei Nie1, Nicole Gormley1, Kirsten B Goldberg1, Amy McKee1, Ann Farrell1, Richard Pazdur1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29365319      PMCID： PMC5786427          DOI： 10.1182/bloodadvances.2017010512

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

1.  Genetic structure of human populations.

Authors:  Noah A Rosenberg; Jonathan K Pritchard; James L Weber; Howard M Cann; Kenneth K Kidd; Lev A Zhivotovsky; Marcus W Feldman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

2.  What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era.

Authors:  Francis S Collins
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

3.  Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.

Authors:  Sikander Ailawadhi; Ibrahim T Aldoss; Dongyun Yang; Pedram Razavi; Wendy Cozen; Taimur Sher; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

Review 4.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

5.  Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.

Authors:  Vishal Bhatnagar; Yin Wu; Olga G Goloubeva; Kathleen T Ruehle; Todd E Milliron; Carolynn G Harris; Aaron P Rapoport; Saul Yanovich; Edward A Sausville; Maria R Baer; Ashraf Z Badros
Journal:  Cancer       Date:  2014-12-02       Impact factor: 6.860

6.  Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.

Authors:  Dianne Pulte; Adam Gondos; Hermann Brenner
Journal:  Oncologist       Date:  2011-10-03

7.  Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Authors:  Adam J Waxman; Pamela J Mink; Susan S Devesa; William F Anderson; Brendan M Weiss; Sigurdur Y Kristinsson; Katherine A McGlynn; Ola Landgren
Journal:  Blood       Date:  2010-09-07       Impact factor: 22.113

8.  Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.

Authors:  Dianne Pulte; Maria Theresa Redaniel; Hermann Brenner; Lina Jansen; Mona Jeffreys
Journal:  Leuk Lymphoma       Date:  2013-09-03

9.  The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.

Authors:  Pramvir S Verma; Robin S Howard; Brendan M Weiss
Journal:  Am J Hematol       Date:  2008-05       Impact factor: 10.047

10.  Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT).

Authors:  Raegan W Durant; Jennifer A Wenzel; Isabel C Scarinci; Debora A Paterniti; Mona N Fouad; Thelma C Hurd; Michelle Y Martin
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860
View more
  7 in total

1.  With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Authors:  Nathanael R Fillmore; Sarvari V Yellapragada; Chizoba Ifeorah; Ansh Mehta; Diana Cirstea; Paul S White; Gustavo Rivero; Andrew Zimolzak; Saiju Pyarajan; Nhan Do; Mary Brophy; Nikhil C Munshi
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

2.  INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma.

Authors:  Caitlin Costello; Faith E Davies; Gordon Cook; Jorge Vela-Ojeda; Jim Omel; Robert M Rifkin; Jesus Berdeja; Noemi Puig; Saad Z Usmani; Katja Weisel; Jeffrey A Zonder; Evangelos Terpos; Andrew Spencer; Xavier Leleu; Mario Boccadoro; Michael A Thompson; Dorothy Romanus; Dawn M Stull; Vania Hungria
Journal:  Future Oncol       Date:  2019-02-28       Impact factor: 3.404

Review 3.  Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature.

Authors:  Stergios Intzes; Marianthi Symeonidou; Konstantinos Zagoridis; Zoe Bezirgianidou; Georgios Vrachiolias; Athina Spanoudaki; Emmanouil Spanoudakis
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

4.  Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.

Authors:  Samer Al Hadidi; Deepa Dongarwar; Hamisu M Salihu; Rammurti T Kamble; Premal Lulla; LaQuisa C Hill; George Carrum; Carlos A Ramos; Helen E Heslop; Saad Z Usmani
Journal:  Leuk Lymphoma       Date:  2021-07-18

5.  Trends in survival from myeloma, 1990-2015: a competing risks analysis.

Authors:  Mary Jane Sneyd; Andrew R Gray; Ian M Morison
Journal:  BMC Cancer       Date:  2021-07-16       Impact factor: 4.430

Review 6.  Dissecting racial disparities in multiple myeloma.

Authors:  Catherine R Marinac; Irene M Ghobrial; Brenda M Birmann; Jenny Soiffer; Timothy R Rebbeck
Journal:  Blood Cancer J       Date:  2020-02-17       Impact factor: 11.037

7.  Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials.

Authors:  Bindu Kanapuru; Laura L Fernandes; Lola A Fashoyin-Aje; Andrea C Baines; Vishal Bhatnagar; Rachel Ershler; Thomas Gwise; Paul Kluetz; Richard Pazdur; Elizabeth Pulte; Yuan-Li Shen; Nicole Gormley
Journal:  Blood Adv       Date:  2022-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.